{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G751A Frameshift-GOF",
                "VariantAlleleFraction": "5.5%"
            },
            {
                "Gene": "PHF6",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R225X Frameshift-GOF",
                "VariantAlleleFraction": "1.07%"
            },
            {
                "Gene": "MET",
                "DNA Alteration": "c.3028G>A",
                "GeneMutation": "p.H1094Y Spliceregionvariant-GOF",
                "VariantAlleleFraction": "10.59%"
            },
            {
                "Gene": "U2AF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R156X Spliceregionvariant-GOF",
                "VariantAlleleFraction": "8.42%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R1012X Spliceregionvariant-GOF",
                "VariantAlleleFraction": "3.98%"
            },
            {
                "Gene": "KRAS",
                "DNA Alteration": "c.37G>C",
                "GeneMutation": "p.Q61P Spliceregionvariant-LOF",
                "VariantAlleleFraction": "9.26%"
            },
            {
                "Gene": "AKT1",
                "DNA Alteration": "c.49G>A",
                "GeneMutation": "p.E17K Nonsense-LOF",
                "VariantAlleleFraction": "1.31%"
            },
            {
                "Gene": "SIX1",
                "DNA Alteration": "c.530A>G",
                "GeneMutation": "p.Q177R Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.66%"
            },
            {
                "Gene": "DICER1",
                "DNA Alteration": "c.5438A>G",
                "GeneMutation": "p.E1813D Spliceregionvariant-LOF",
                "VariantAlleleFraction": "1.35%"
            },
            {
                "Gene": "PTPN11",
                "DNA Alteration": "c.1508G>C",
                "GeneMutation": "p.G503A Nonsense-LOF",
                "VariantAlleleFraction": "8.67%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.954G>T",
                "GeneMutation": "p.E318D Spliceregionvariant-GOF",
                "VariantAlleleFraction": "9.32%"
            },
            {
                "Gene": "MYD88",
                "DNA Alteration": "c.794T>C",
                "GeneMutation": "p.L265P Frameshift-GOF",
                "VariantAlleleFraction": "1.08%"
            }
        ],
        "Germline": []
    }
}